electroCore to Present at the LD Micro Invitational XVI Conference on May 18, 2026
electroCore Announces First Quarter 2026 Financial Results
electroCore TAC-STIM™ Named National Semifinalist in National Safety Council Work to Zero Challenge
electroCore to Announce First Quarter March 31, 2026, Financial Results on Wednesday, May 6, 2026
The science of nVNS
nVNS therapy stimulates the vagus nerve, which has been proven to help people suffering from a variety of disorders.
Pioneers of technology. Innovators of medicine.
We are pioneering the use of nVNS to deliver bioelectronic medicine for patient benefit.
Our Products. Our Passion.
Find innovative health and wellness solutions with electroCore's products, all utilizing our proprietary vagus nerve stimulation technology.
electroCore is committed to the safety and care of our patients, providers, and employees during the COVID-19 pandemic. We have implemented several operational enhancements, research initiatives, and virtual capabilities to ensure patients who depend on us have uninterrupted access to gammaCoreTM (non-invasive vagus nerve stimulator). To learn more about our efforts please call (888) 903-CORE.
